Event Date/Time: Mar 06, 2006
End Date/Time: Mar 07, 2006
The quality and safety of blood and blood products is a major concern to the health community. The goal is to prevent, as completely as possible, the transmission of infectious or potentially dangerous particles. How can this goal be reached? What are the newest and most precise screening assays? Which agents need to be screened for? Which new pathogens are a potential threat to humans? How early can pathogens be detected? Which donors are being excluded/included? Which effect has pooled screening on the window-period?